logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

俄羅斯新增病例創新高 首款疫苗正式註冊

亞歐地區多國新冠疫情持續惡化,俄羅斯4日報告的單日新增確診病例數創下新高。超過1萬9千例,新增死亡病例389例也創新高,全球首支新冠病毒疫苗已於昨天在俄羅斯完成註冊,它被命名為「衛星-V」。

據俄羅斯防疫指揮部4日消息,過去24小時俄新增新冠確診病例19,768例,創歷史新高,累計1,693,454例;新增死亡病例389例也創新高,累計死亡29,217例。俄羅斯衛生部長助理庫茲涅佐夫(Alexei Kuznetsov)表示,俄衛生部門正採取一切措施防止疫情蔓延,目前的問題是醫院超負荷運轉及醫務人員短缺。

此外,由俄羅斯研製的全球首支新冠病毒疫苗已於週二在俄羅斯完成註冊,它被命名為「衛星-V」疫苗將在兩地開始生產,分別是加馬列亞研究中心和俄疫苗生產商Binnopharm公司。醫生和教師將成為首批接種人群。

阿根廷衛生部表示,希望在12月收到俄「衛星-V」疫苗,阿根廷衛生部長岡薩雷斯表示,阿根廷政府尚未簽署俄羅斯「衛星-V」疫苗供應協議,但打算這樣做,並希望在12月收到大量藥品。

岡薩雷斯指出,阿根廷政府的初步計劃是,所購「衛星-V」疫苗可供1250萬國民接種。岡薩雷斯表示阿根廷希望盡快啟動疫苗接種,但並未說明暫定的時間框架。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 共和黨參議院多數黨領袖 麥康奈爾勝選連任
Next post 喬州重新點票 共和黨要求法院暫停賓州選舉日後選票計票

即時新聞

佛州空軍基地設爆炸裝置 鄭姓姊弟面臨聯邦指控

March 26, 2026

馬杜羅夫妻出庭受審 訴訟費用問題未決

March 26, 2026

川普稱美方軍事行動超預期 伊朗渴望達協

March 26, 2026

國際奧委會禁跨性別女運動員參加女子奧運

March 26, 2026

白宮:川普擬5/14至15日訪華 習近平將回訪華府

March 25, 2026
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Privacy Policy - Terms and Conditions